High-Capacity Fill-Finish
Solutions at Scale
helps manufacture your products efficiently and reliably.
IDT Biologika, part of SK bioscience, is a global CDMO providing end-to-end solutions for cell-culture and microbial-based proteins, monoclonal antibodies, vaccines, gene and immune therapeutics, biosimilars, and sterile injectables.
With more than 100 years of biopharmaceutical experience, we partner with pharmaceutical and biotech companies throughout the entire product lifecycle – from development and technology transfer to commercial manufacturing.
Our integrated service offering includes process and analytical development, drug substance manufacturing, aseptic fill-finish, secondary packaging, and quality control. Combining flexibility, operational excellence, and regulatory expertise, we help accelerate product development and market readiness.
Leveraging proprietary technologies, including in-house cell lines, and the expertise of highly experienced teams, we enable seamless technology transfer, efficient scale-up, and reliable manufacturing for clinical and commercial programs.
With passion we bring pharmaceutical solutions to life.
Strategic Locations
Sales Office
First point of contact for American customers to discover and utilize our end-to-end services in contract development and manufacturing of vaccines, gene & immune therapeutics and sterile injectables.
<p class="heading-4 mb-4 text-navy-500">IDT Biologika at a Glance</p>
Year Founded 1921
1,600
employees
2 BSL-2 Sites
Worldwide Services for the global biopharmaceutical industry and governments
Over 30 years of experience in commercial filling of pharmaceuticals
More than 200 development, clinical and commercial projects in recent years
Over € 600 m
invested since 1993, including € 400 m since 2011
More than a century of experience in development and production of vaccines
Approvals
EMA, FDA, ANVISA
First German company which has its pandemic readiness confirmed by the German government.
IDT Biologika works with a range of cell lines qualified to current regulations, including proprietary cell lines that can eliminate the need for characterization and other non-proprietary cell lines commonly used in viral manufacturing.
IDT Biologika leverages experience with hundreds of vaccines to find the best way to develop a client’s process. We work with virtually every relevant upstream and downstream technology, so we can recommend the optimal one.
IDT Biologika offers comprehensive analytical development services, including fast-track analytical methods to deliver a competitive advantage to customers from process development through scale-up to commercial manufacturing.
IDT Biologika is one of the world’s most experienced vaccine CDMOs, and a manufacturer capable of assisting with the global underserved need for viral vectors. Our GMP and BSL-2 facilities meet client needs for drug substance from early clinical to commercial scale.
There are virtually no upstream or downstream methods used today that we do not offer. Every process is different, so when process technology is not yet defined by our client, we will evaluate the parameters and define which of several leading technologies we offer will be optimal based on past experience and knowledge.
We provide aseptic liquid filling and lyophilization in vials and pre-filled syringes as an integrated complement to our vaccine drug substance contract manufacturing and as an independent service for all sterile injectables, at clinical and commercial scale.
As a biologics contract manufacturing company offering aseptic filling and lyophilization in vials and pre-filled syringes, we also offer secondary packaging and cold chain storage services to meet the needs of companies with clinical manufacturing requirements and commercial products.
Close cooperation of quality experts with manufacturing and engineering activities is key to a reliable supply of high-quality vaccines and pharmaceuticals. This makes internal communication and exchanges with clients very fast and to-the-point.
IDT Biologika has an exceptionally strong regulatory track record. Our facilities have been subject to hundreds of audits from clients and agencies, and we have longstanding expertise in guiding customers through regulatory requirements.
Media & Events
16 – 17 September 2026
Sheraton Brussels Airport Hotel, Belgium
Careers
If you want to further your career with a global leader in vaccines, gene and immune therapeutics, and sterile injectables CDMO services, visit IDT Biologika’s careers section.